Andreas Evers

2.3k citations

55 papers · 1.6k indexed · h-index 21

Impact in

Computational Theory and Mathematics top 1%
- Computational Drug Discovery Methods
Endocrinology, Diabetes and Metabolism top 5%
- Diabetes Treatment and Management

Papers in ⓘ

Cellular and Molecular Neuroscience 12
- Neuropeptides and Animal Physiology 12
Radiology, Nuclear Medicine and Imaging 15
- Monoclonal and Polyclonal Antibodies Research 15

Co-authors: Thomas Klabunde (5 shared papers)G. Klebe (6 shared papers)Michael Wagner (13 shared papers)M. Lorenz (5 shared papers)Gerhard Heßler (7 shared papers)Hans Matter (3 shared papers)Holger Gohlke (1 shared paper)Martin Bossart (10 shared papers)
Journals: Journal of Medicinal Chemistry (12 papers)mAbs (8 papers)Protein Science (3 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)ChemMedChem (2 papers)
Partner nations: Germany France United States

In The Last Decade

Andreas Evers

55 papers receiving 1.6k citations

Peers

Countries citing papers authored by Andreas Evers

Since Specialization

Citations

This map shows the geographic impact of Andreas Evers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Evers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Evers more than expected).

Fields of papers citing papers by Andreas Evers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Evers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Evers. The network helps show where Andreas Evers may publish in the future.

Co-authors

The 25 scholars most cited alongside Andreas Evers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andreas Evers Line = papers co-authored together Andreas Evers links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Structure-based Drug Discovery Using GPCR Homology Modeling: Successful Virtual Screening for Antagonists of the Alpha1A Adrenergic Receptor Journal of Medicinal Chemistry ·Andreas Evers, Thomas Klabunde	2005	178
2	Virtual Screening of Biogenic Amine-Binding G-Protein Coupled Receptors: Comparative Evaluation of Protein- and Ligand-Based Virtual Screening Protocols Journal of Medicinal Chemistry ·Andreas Evers, Gerhard Heßler, Hans Matter, Thomas Klabunde	2005	127
3	Successful Virtual Screening for a Submicromolar Antagonist of the Neurokinin-1 Receptor Based on a Ligand-Supported Homology Model Journal of Medicinal Chemistry ·Andreas Evers, G. Klebe	2004	126
4	Comparison of Structure‐ and Ligand‐Based Virtual Screening Protocols Considering Hit List Complementarity and Enrichment Factors ChemMedChem ·Dennis Krüger, Andreas Evers	2009	96
5	Recent progress and future options in the development of GLP-1 receptor agonists for the treatment of diabesity Bioorganic & Medicinal Chemistry Letters ·M. Lorenz, Andreas Evers, Michael Wagner	2013	95
6	Design of Novel Exendin-Based Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists Journal of Medicinal Chemistry ·Andreas Evers, Torsten Haack, M. Lorenz, Martin Bossart, Ralf Elvert, Bernd Henkel, Siegfried Stengelin, Michael Kurz, Maike Glien, Angela Dudda, Katrin Lorenz, Dieter Kadereit, Michael Wagner	2017	89
7	Ligand-supported Homology Modelling of Protein Binding-sites using Knowledge-based Potentials Journal of Molecular Biology ·Andreas Evers, Holger Gohlke, G. Klebe	2003	86
8	Ligand‐Supported Homology Modeling of G‐Protein‐Coupled Receptor Sites: Models Sufficient for Successful Virtual Screening Angewandte Chemie International Edition ·Andreas Evers, G. Klebe	2003	71
9	GPCR Antitarget Modeling: Pharmacophore Models for Biogenic Amine Binding GPCRs to Avoid GPCR‐Mediated Side Effects ChemBioChem ·Thomas Klabunde, Andreas Evers	2005	58
10	Sequence-Derived Three-Dimensional Pharmacophore Models for G-Protein-Coupled Receptors and Their Application in Virtual Screening Journal of Medicinal Chemistry ·Thomas Klabunde, Clemens Giegerich, Andreas Evers	2009	47
11	Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists Specifically Optimized for Multidose Formulations Journal of Medicinal Chemistry ·Andreas Evers, Martin Bossart, Stefania Pfeiffer‐Marek, Ralf Elvert, Herman Schreuder, Michael Kurz, Siegfried Stengelin, M. Lorenz, Andreas W. Herling, Anish Konkar, Ulrike Lukasczyk, Anja Pfenninger, Katrin Lorenz, Torsten Haack, Dieter Kadereit, Michael Wagner	2018	40
12	Novel Small Molecule Inhibitors of Activated Thrombin Activatable Fibrinolysis Inhibitor (TAFIa) from Natural Product Anabaenopeptin Journal of Medicinal Chemistry ·Nis Halland, Mark Brönstrup, Jörg Czech, Werngard Czechtizky, Andreas Evers, Markus Follmann, Markus Kohlmann, Matthias Schiell, Michael Kurz, Herman Schreuder, Christopher Kallus	2015	37
13	Incretin combination therapy for the treatment of non‐alcoholic steatohepatitis Diabetes Obesity and Metabolism ·Aimo Kannt, Andreas Nygaard Madsen, Claire Kammermeier, Ralf Elvert, Tim Klöckener, Martin Bossart, Torsten Haack, Andreas Evers, Katrin Lorenz, Wolfgang Hennerici, Corinne Rocher, Zsolt Böcskei, Jean‐Claude Guillemot, Vincent Mikol, François Pattou, Bart Staels, Michael Wagner	2020	33
14	Selective non-lipid modulator of LPA5 activity in human platelets Bioorganic & Medicinal Chemistry Letters ·Detlef Kozian, Andreas Evers, Peter Florian, Peter Wonerow, Sabrina Joho, Marc Nazaré	2012	32
15	Crystal Structure of 2-Methylisocitrate Lyase (PrpB) from Escherichia coli and Modelling of its Ligand Bound Active Centre Journal of Molecular Biology ·Clemens Grimm, Andreas Evers, Matthias Brock, Claudia Maerker, G. Klebe, Wolfgang Buckel, Klaus Reuter	2003	32
16	Running on mixed fuel‐dual agonistic approach of GLP‐1 and GCG receptors leads to beneficial impact on body weight and blood glucose control: A comparative study between mice and non‐human primates Diabetes Obesity and Metabolism ·Ralf Elvert, Andreas W. Herling, Martin Bossart, Tilo Weiß, Baohong Zhang, Pierre Wenski, Jörn Wandschneider, Sabrina Kleutsch, Uwe Butty, Aimo Kannt, Michael Wagner, Torsten Haack, Andreas Evers, Angela Dudda, M. Lorenz, Stefanie Keil, Philip J. Larsen	2018	30
17	Identification of High-Affinity P2Y₁₂Antagonists Based on a Phenylpyrazole Glutamic Acid Piperazine Backbone Journal of Medicinal Chemistry ·Gernot Zech, Gerhard Heßler, Andreas Evers, Tilo Weiß, Peter Florian, Melitta Just, Jörg Czech, Werngard Czechtizky, Jochen Görlitzer, Sven Ruf, Markus Kohlmann, Marc Nazaré	2012	30
18	Beyond bispecificity: Controlled Fab arm exchange for the generation of antibodies with multiple specificities mAbs ·Desislava Yanakieva, Lukas Pekar, Andreas Evers, Markus Fleischer, Stephan Sylvest Keller, Dirk Mueller-Pompalla, Lars Toleikis, Harald Kolmar, Stefan Zielonka, Simon Krah	2022	26
19	Multiple-Ligand-Based Virtual Screening: Methods and Applications of the MTree Approach Journal of Medicinal Chemistry ·Gerhard Heßler, Marc Zimmermann, Hans Matter, Andreas Evers, Thorsten Naumann, Thomas Lengauer, Matthias Rarey	2005	25
20	The Potential of P1 Site Alterations in Peptidomimetic Protease Inhibitors as Suggested by Virtual Screening and Explored by the Use of CC‐Coupling Reagents ChemMedChem ·Steffen Weik, Torsten Luksch, Andreas Evers, Jark Böttcher, Christoph Sotriffer, Andrej Hasilík, Hans‐Gerhard Löffler, G. Klebe, Jörg Rademann	2006	24

About Andreas Evers

Andreas Evers is a scholar working on Cellular and Molecular Neuroscience, Radiology, Nuclear Medicine and Imaging, Endocrinology, Diabetes and Metabolism, Molecular Biology and Computational Theory and Mathematics, having authored 55 papers that have together received 1.6k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (15 papers), Receptor Mechanisms and Signaling (14 papers), Neuropeptides and Animal Physiology (12 papers), Diabetes Treatment and Management (10 papers), Chemical Synthesis and Analysis (9 papers), Computational Drug Discovery Methods (9 papers), Protein purification and stability (7 papers) and CAR-T cell therapy research (5 papers). The work is most often cited by research in Computational Theory and Mathematics (528 citations), Endocrinology, Diabetes and Metabolism (281 citations), Molecular Biology (1.1k citations), Cellular and Molecular Neuroscience (280 citations) and Radiology, Nuclear Medicine and Imaging (275 citations). Andreas Evers has collaborated with scholars based in Germany, France and United States. Frequent co-authors include Thomas Klabunde, G. Klebe, Michael Wagner, M. Lorenz, Gerhard Heßler, Hans Matter, Holger Gohlke, Martin Bossart, Torsten Haack and Ralf Elvert. Their work appears in journals such as Journal of Medicinal Chemistry, mAbs, Protein Science, Bioorganic & Medicinal Chemistry Letters and ChemMedChem.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact